[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"liver-function\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:liver-function":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100507447","effects-of-vitamin-d-status-and-multiple-mega-dose-supplementation-on-health-care-disparities-in-perioperative-patients-with-hepatocellular-carcinoma-receiving-hepatectomy-100507447",false,"NCT05887505","Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy","Inclusion Criteria:\n\n* 1\\. ≥ 20-year HCC subjects receiving laparoscopic hepatectomy\n* 2.Sign the informed consent\n\nExclusion Criteria:\n\n* 1\\. Using estrogen drugs, bisphosphonates, or drugs for bone disease.\n* 2\\. Consume calcium tablets within 2 weeks before operation\n* 3\\. Sarcoidosis, multiple myeloma\n* 4\\. Pregnant women or plan to become pregnant within 3 months after surgery\n* 5\\. Autoimmune hepatitis (AIH)\n* 6\\. Early liver recurrence\n* 7\\. Used to participate in other clinical trials","ALL","20 Years",{"count":18,"type":19},120,"ESTIMATED","INTERVENTIONAL",[22],"NA","High concentrations of parathyroid hormone (PTH) are common in patients with hepatocellular carcinoma (HCC). This study is aimed to investigate effects of vitamin D status and its multiple mega-dosage supplementation on PTH and clinical outcomes in HCC patients before and after hepatectomy. It's a single-center, prospective, parallel, double-blind, placebo-controlled study for 120 eligible subjects. The subjects will receive consecutively 3-day intervention treatments from 7th day before surgery. 30-day postoperative mortality, postoperative complications, and laboratory data will be evaluated.",[25,26,27],"Hepatocellular Carcinoma","Liver Function","Postoperative Complications",[29,30,31],"Vitamin D Supplementation","Hepatectomy","Perioperative","NOT_YET_RECRUITING","2023-06-04",{"date":35,"type":36},"2023-06-06","ACTUAL",{"date":38,"type":19},"2023-06-09",{"date":40,"type":19},"2027-12-31",{"name":42,"class":43},"Taoyuan General Hospital","OTHER_GOV"]